Teva acquires Emalex Biosciences for up to $900m
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced it has signed a definitive agreement to acquire Emalex ...
Wednesday, July 1, 2026
Tag: Emalex
-1024x683.jpg "Florida Roads Become a Battleground for Illegal Immigration")
-1024x683.jpg "TPS Migrants Must Legalize or Leave – And Nobody’s Happy")
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.